Stock ARCOMA ARCOMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Arcoma AB

Equities

ARCOMA

SE0006219176

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
17.15 SEK +0.29% Intraday chart for Arcoma AB +1.18% +115.72%
Apr. 25 Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 29 Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
ARCOMA AB Stock Arcoma AB
+115.72% 21.47M -
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-22.15% 12.06B -
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-53.95% 2.1B
C-
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-27.75% 1.2B - -
CORETAG, INC. Stock Coretag, Inc.
-.--% 1.12B - -
GUERBET Stock Guerbet
+99.49% 534M
B+
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+39.87% 515M -
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
+27.37% 279M
C
DRTECH CORPORATION Stock DRTECH Corporation
-13.97% 197M - -
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+2.96% 186M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. ARCOMA Stock
  4. Ratings Arcoma AB